Public Profile

Arbor Pharmaceuticals, LLC

Arbor Pharmaceuticals, LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and marketing of innovative products for the paediatric and adult markets. Founded in 2006, Arbor has achieved significant milestones, including the expansion of its product portfolio and strategic partnerships that enhance its market presence. The company focuses on niche therapeutic areas, offering unique formulations and delivery systems that cater to specific patient needs. Arbor's commitment to quality and innovation has positioned it as a trusted provider in the healthcare sector, with a growing reputation for excellence in paediatric care. With a robust pipeline and a dedication to improving patient outcomes, Arbor Pharmaceuticals continues to make strides in the competitive pharmaceutical landscape.

DitchCarbon Score

How does Arbor Pharmaceuticals, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Arbor Pharmaceuticals, LLC's score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

80%

Arbor Pharmaceuticals, LLC's reported carbon emissions

Arbor Pharmaceuticals, LLC, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions. Companies are encouraged to adopt science-based targets and engage in initiatives that promote environmental responsibility. Arbor Pharmaceuticals may be exploring such avenues to align with industry standards and contribute to climate action, but specific details on their commitments or initiatives are not provided.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Arbor Pharmaceuticals, LLC's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Arbor Pharmaceuticals, LLC is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Arbor Pharmaceuticals, LLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Prestige Consumer Healthcare Inc

GB
Health and social work services (85)
Updated 6 days ago

Otonomy, Inc.

US
Health and social work services (85)
Updated 8 days ago

Alcon

CH
Health and social work services (85)
Updated 6 days ago

Abeona Therapeutics Inc.

US
Health and social work services (85)
Updated 5 days ago

Janssen

US
Health and social work services (85)
Updated 8 days ago

Novartis Pharmaceuticals Corporation

US
Chemicals nec
Updated 8 days ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers